Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider
Nykode Therapeutics ASA (NYKD) · publisert 25. oktober 2023 kl. 17:22 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Christian Åbyholm via Victoria India Fund AS | Styremedlem | Kjøp | 450 000 | 18,0244 NOK | 25. oktober 2023 | NO0010714785 | XOSL - Oslo Stock Exchange |
| Christian Åbyholm via Caaby AS | Styremedlem | Kjøp | 50 000 | 18,0244 NOK | 25. oktober 2023 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- 20231025 Attachment.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, October 25, 2023
Victoria India Fund AS has today acquired 450,000 shares in Nykode Therapeutics ASA at an average price of NOK 18.0244 per share. Christian Åbyholm is a Member of the Board of Victoria India Fund AS and is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction Victoria India Fund AS holds 17,705,175 shares in the Nykode Therapeutics ASA.
Caaby AS has today acquired 50,000 shares in Nykode Therapeutics ASA at an average price of NOK 18.0244 per share. Christian Åbyholm is the owner of Caaby AS and is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction Christian Åbyholm holds 2,055,295 shares in Nykode Therapeutics ASA through Caaby AS and 100,000 shares directly.
For further details, please see the attached forms.